
Weight Loss
GLP-1 Medications for Weight Loss and Diabetes
Compare semaglutide and tirzepatide for weight loss, learn which GLP-1 pills work, and understand side effects, stopping, and pharmacy fulfillment.
GLP-1 weight loss
Medical weight loss pairs prescription medication with clinician support and healthy habits. At PEPLIX, a U.S.-licensed clinician reviews your health online and, if appropriate, prescribes compounded tirzepatide or semaglutide, once-weekly injections that reduce appetite and help you feel full on less food. Your dose is increased gradually as you progress.

Injection, once weekly
Tirzepatide
Adults with obesity, or overweight with a weight-related health condition, who want a once-weekly dual-action option.
From $279.99/mo →
Injection, once weekly
Semaglutide
Adults with obesity, or overweight with a weight-related health condition, who want a well-studied once-weekly GLP-1.
From $199.99/mo →
After 35, many adults gradually lose muscle, move less and sleep less, while hormones such as estrogen and testosterone shift. These changes lower daily calorie burn and can increase hunger, so the same diet and exercise often produce smaller results. GLP-1 medications target the appetite signals that willpower alone struggles to override.
GLP-1 medications copy a natural gut hormone released after you eat. They slow how quickly the stomach empties, signal fullness to the brain and quiet food cravings, so you feel satisfied with smaller portions. Tirzepatide also activates a second hormone, GIP. Both are injected once a week, with the dose increased step by step.
In separate brand-name trials, tirzepatide produced more average weight loss (about 21% at 72 weeks) than semaglutide (about 15% at 68 weeks), and a 2025 head-to-head trial also favored tirzepatide. Semaglutide has a longer track record and costs less. Your clinician weighs your goals, health history and budget to recommend one.
| Tirzepatide | Semaglutide | |
|---|---|---|
| Hormones it acts on | GLP-1 + GIP | GLP-1 |
| How it’s taken | Weekly injection | Weekly injection |
| Average loss in brand-name trials | ~21% at 72 weeks (SURMOUNT-1) | ~15% at 68 weeks (STEP 1) |
| Most common side effects | Nausea, diarrhea, constipation | Nausea, diarrhea, constipation |
| FDA-approved brand names | Zepbound®, Mounjaro® | Wegovy®, Ozempic® |
| PEPLIX price | From $279.99/mo | From $199.99/mo |
Adults usually qualify with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, high cholesterol, prediabetes, type 2 diabetes or sleep apnea. You may not qualify if you are pregnant, have had pancreatitis, or have a personal or family history of medullary thyroid cancer or MEN 2.
| Height | BMI 27 | BMI 30 |
|---|---|---|
| 5′4″ | 157 lb | 175 lb |
| 5′7″ | 172 lb | 192 lb |
| 5′10″ | 188 lb | 209 lb |
| 6′0″ | 199 lb | 221 lb |
Many people notice less hunger within the first few weeks. Weight loss is usually gradual for the first two to three months while the dose increases, then steadier once you reach your maintenance dose. In trials, most people reached their largest losses after about a year. Results vary and depend on dose and habits.
Yes, when a clinician licensed in your state evaluates you through telehealth and writes a valid prescription, and a licensed pharmacy fills it. PEPLIX follows that process: an online assessment, a clinician review, lab work if needed, and medication shipped from a licensed U.S. pharmacy. Be cautious of sellers that skip the clinician review.
Appetite usually returns within weeks of stopping, and many people regain weight. In the STEP 1 extension study, people who stopped brand-name semaglutide regained about two-thirds of the weight they had lost within a year. Building nutrition, strength-training and sleep habits during treatment helps, and your clinician can plan a gradual taper.
They contain the same active ingredients, semaglutide or tirzepatide, but are prepared by a licensed compounding pharmacy for an individual patient. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality. Brand-name versions are FDA-approved and made by their manufacturers.
Compounded semaglutide starts at $199.99 per month and compounded tirzepatide at $279.99 per month on a six-month plan, with higher monthly prices for shorter plans. There is no membership fee and insurance is not required. Prices can vary slightly by dose and state, and lab work may cost extra.
This page is general education, not medical advice. A licensed clinician decides whether any treatment is right for you. See our safety information.
Compounded medications are not approved or evaluated for safety, efficacy, or quality by the FDA.